Greenphire launches app expanding convenience for patients in clinical trials

By Liza Laws

- Last updated on GMT

© Getty Images
© Getty Images

Related tags digital technology Greenphire Patient centricity patient engagement Data management

Greenphire, a company that finds solutions for companies wanting to run clinical trials has launched a new patient-facing digital platform.

The company says the platform called GreenSpace can help sponsors, CROs and sites to deliver consistency for people taking part in clinical trials. It says the platform will ‘dramatically improve’ access, engagement and retention with its increased international payment function and flexibility.

Greenphire says unlike other solutions, GreenSpace offers a unified digital experience accessible via iOS and Android devices, or through an internet browser. The platform provides easy access to trial-related information and activities such as financial views and account details, submission of receipts for reimbursement, visit and travel itinerary details, delivery of surveys and insights and more.

Kyle Cunningham, chief product officer, at Greenphire said: “We are dedicated to making the patient journey better in every way. With the launch of GreenSpace, we have taken a giant leap forward in achieving that goal by streamlining how patients interact with sites, track clinical trial activities, and get reimbursed.

“We are proud to be at the forefront of patient and site centric innovation, delivering a game-changing product that is transforming patient experiences around the world.”

He said in addition to the new platform, the company has also expanded its proven global payment offerings available through ClinCard, the industry's leading technology for international patient reimbursement automation.

The company says patients’ needs around the world can be met by offering payment methods for both banked and unbanked study populations. They say this puts the power into the hands of the trial participants giving them options including reloadable debit and virtual cards, digital wallets, email to money and bank transfers in real time. They say there is a low cost to customers and zero fees for patients.

“Persistent financial and logistical burdens remain a key impediment to patient involvement in clinical trials," said Jim Murphy, CEO, at Greenphire.

“Our core objective at Greenphire is to break down those barriers – to understand the challenges faced by sponsors and CROs, sites and participants, and continuously deliver scalable technology solutions that broaden access, drive convenience, and introduce efficiency and transparency worldwide.”

Additional features and functionalities will be deployed throughout the year.

Related news

Show more

Related products

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Related suppliers